Northern RNA Inc.
$15,000,000.00 CAD
- Program
- SIF Stream 2 - Growth
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- August 10, 2023 – January 1, 2050
- Reference
- ic:033-2023-2024-Q2-819504
Published purpose
This project is to build a Good Manufacturing Practices (GMP) facility to manufacture lipids, conduct lipid nanoparticle (LNP) formulation and expand the company's existing vaccine manufacturing capacity in Calgary, AB.
In plain English AI-generated
This project funds the construction of a Good Manufacturing Practices (GMP) facility in Calgary, Alberta, to produce lipids, formulate lipid nanoparticles, and expand vaccine manufacturing capacity.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.